NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.00

25 Jun
2026

0.100

OPEN

$6.95

1.45%

HIGH

$7.07

1,278,994

LOW

$6.94

TARGET
$7.30 4.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 38.4 45.8 xxx
DPS (cps) xxx 34.0 31.5 xxx
EPS Growth xxx - 6.5% 19.0% xxx
DPS Growth xxx 17.2% - 7.4% xxx
PE Ratio xxx N/A 14.4 xxx
Dividend Yield xxx N/A 4.8% xxx
Div Pay Ratio(%) xxx 88.5% 68.9% xxx

Dividend yield today if purchased 3 years ago: 4.40%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 5.18

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 03/09 - ex-div 16.00c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx38.4
DPS All xxxxxxxxxxxxxxx34.0
Sales/Revenue xxxxxxxxxxxxxxx3,817.3 M
Book Value Per Share xxxxxxxxxxxxxxx233.2
Net Operating Cash Flow xxxxxxxxxxxxxxx199.1 M
Net Profit Margin xxxxxxxxxxxxxxx4.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx16.58 %
Return on Invested Capital xxxxxxxxxxxxxxx13.56 %
Return on Assets xxxxxxxxxxxxxxx8.54 %
Return on Equity xxxxxxxxxxxxxxx16.58 %
Return on Total Capital xxxxxxxxxxxxxxx19.36 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx36.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx20 M
Long Term Debt xxxxxxxxxxxxxxx210 M
Total Debt xxxxxxxxxxxxxxx230 M
Goodwill - Gross xxxxxxxxxxxxxxx315 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx217 M
Price To Book Value xxxxxxxxxxxxxxx3.03

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx34.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.90 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx128 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,109 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

5

xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

01/06/2026

1

Buy

$7.70

10.00%

Citi notes private health insurance industry conditions softened in the March quarter, with headline net margins falling to 3.6% from 5.5% a year earlier following an exceptionally strong FY25 profit cycle.

The broker estimates underlying claims inflation at 3.7% on a benefits-paid-per-person basis, supporting the industry's average 4.41% premium increase implemented in April.

With higher pricing now in place, the analysts expect margins at nib Holdings and Medibank Private to remain well supported.

While fund transfers have risen to a record 6% of insured members, commentary notes participation also reached a record high, with 55.5% of Australians holding some form of private health insurance.

Target of $7.70 and Buy rating for nib Holdings.

FORECAST
Citi forecasts a full year FY26 dividend of 27.00 cents and EPS of 43.90 cents.
Citi forecasts a full year FY27 dividend of 31.50 cents and EPS of 49.00 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

03/03/2026

2

Overweight

$7.65

9.29%

The first half results from nib Holdings fell short of Jarden's expectations in two main areas: ARHI policy growth dropped to 2.2% and underlying operating profit in New Zealand was just 50% of estimates.

Forecasts are trimmed by -5-7% to reflect more modest growth in ARHI and a faster normalisation of the ARHI net margin. Given the downgrading impact of NZ results, the broker expects a recovery in that jurisdiction will be significantly more protracted.

With the stock trading at a -24% discount to its long-term average and rival Medibank Private ((MPL)), Jarden believes risks are appropriately factored in and reiterates an Overweight rating. Target is reduced to $7.65 from $8.20.

FORECAST
Jarden forecasts a full year FY26 dividend of 26.00 cents and EPS of 36.70 cents.
Jarden forecasts a full year FY27 dividend of 28.00 cents and EPS of 45.50 cents.
Access Extra Coverage Research History >

NHF STOCK CHART

FNArena News on NHF

Latest Insurance News

1
Climate Costs Burden Heaviest For Aussie Insurers

Jun 01 2022 - Australia
2
In Brief: Risks From Russia, House Prices And Insurance Brokers

Feb 04 2022 - Australia
3
IAG Fails The Weather Test, But All Is Not Lost

Nov 03 2021 - Australia
4
Growth Returns For Suncorp

Aug 10 2021 - Australia
5
Treasure Chest: IAG Re-Rating?

Jun 28 2021 - Treasure Chest
6
Insurers Grapple With Costs And Competition

Jun 16 2021 - Australia
7
Nib Holdings May Need To Tread Carefully

Apr 27 2021 - Australia
8
Insurers Tackle More Risk As NSW Floods

Mar 23 2021 - Australia
9
Suncorp Homes In On Improved Returns

Feb 10 2021 - Australia
10
Reinsurance Key To Insurer Pandemic Claims

Sep 16 2020 - Australia